Chandra Bhagat Pharma Limited has submitted a prior intimation to BSE Limited regarding an upcoming Board of Directors meeting scheduled for Wednesday, 5th August 2026. The intimation is made pursuant to Regulation 29(1)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The Board Meeting agenda includes:
- Consideration of increasing the Authorised Share Capital of the Company
- Consideration of a fundraising proposal through the issue of Equity Shares, convertible warrants, and/or any other instruments via Preferential allotment. The consideration may be for cash or other than cash, subject to shareholder approval and compliance with applicable provisions of law
- Fixing the date, time, and place for holding an Extra Ordinary General Meeting to obtain shareholders' approval for the preferential issue and other agenda items
- Any other business with the permission of the chair that is incidental and ancillary to the main business
Additionally, the company has implemented a trading window closure pursuant to its Code of Conduct for prevention of insider trading, framed in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window remains closed for all connected persons, officers, designated employees, insiders, directors of the Company, and their immediate relatives from 30th July 2026 until the end of 48 hours after the conclusion of the Board Meeting.